Skip to main content
Psomagen, Inc. logo

Psomagen, Inc. — Investor Relations & Filings

Ticker · 950200 ISIN · KR8840150005 KO Professional, scientific and technical activities
Open in API
Filings indexed 180 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country US United States of America
Listing KO 950200

About Psomagen, Inc.

https://www.psomagen.com/

Psomagen, Inc. is a contract laboratory service provider specializing in multiomics and data analysis solutions for scientists and clinicians. Operating from CLIA-certified and CAP-accredited facilities, the company offers a comprehensive suite of services to the academic, clinical, and life sciences research communities. Its core offerings encompass genomics, epigenomics, proteomics, transcriptomics, and metagenomics. Psomagen utilizes a range of sequencing technologies, including Sanger sequencing, Next-Generation Sequencing (NGS), and third-generation sequencing. The company also provides specialized solutions such as spatial biology analysis, cell line authentication via STR profiling, and advanced bioinformatics support to analyze complex biological data.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” and covers the 23rd term 1st quarter period (2026.01.01–2026.03.31). It includes full sections such as company overview, business content, summary financial information, consolidated financial statements and notes, management’s analysis, and auditor’s opinion. It is a comprehensive quarterly financial report containing actual financial data rather than merely announcing or linking to another report. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a Korean corporate disclosure titled ‘정기주주총회 결과’ (Annual General Meeting Results) and provides the outcomes of shareholder votes on financial statement approval, director elections, and other AGM agenda items, including voting percentages. This corresponds to a Declaration of Voting Results & Voting Rights Announcement, not an actual AGM presentation or full report.
2026-03-31 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 82% confidence The document is a corrected notice of convocation for the annual general meeting (주주총회소집공고 정정), including agenda items (approval of financial statements) and the full financial statements for shareholder review ahead of the vote. This fits the definition of proxy solicitation/information materials provided to shareholders to inform and request votes at the AGM. Therefore, it should be classified as a Proxy Solicitation & Information Statement (PSI).
2026-03-24 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 22nd fiscal year (2025), which is the Korean equivalent of an Annual Report (10-K). It contains comprehensive sections including company overview, business details, financial statements, management discussion and analysis (MDA), and governance information. It is a full-length regulatory filing submitted to the Financial Services Commission and the Korea Exchange, not an announcement or a summary. FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document’s title and content revolve around the submission of the company’s audit report (“감사보고서 제출”), detailing the auditor’s opinion, auditor name, receipt date, and consolidated/separate financial statement figures under audit. It is not a full annual report or mere announcement but a standalone audit report filing. Therefore, it matches the Audit Report / Information category. FY 2025
2026-03-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Psomagen, Inc. It includes the meeting date, location, agenda items (financial statements, director appointments, remuneration), and proxy voting instructions. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and request their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2026-03-13 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.